Literature DB >> 29403254

Primary dorsal spine primitive neuroectodermal tumor in an adult patient: Case report and literature review.

Satyashiva Munjal1, Amit Srivastava1, Shivya Tucker2, Neha Bakshi3, Sunita Bhalla3, V S Mehta1.   

Abstract

Primary spinal primitive neuroectodermal tumor (psPNET) is a rare entity with few cases reported in literature. We report a case of a 50-year-old female who presented to us with paraplegia and was diagnosed with extradural dorsal spine psPNET. The diagnosis was not suspected at presentation or on radiology but was established on histopathological examination. It is important to distinguish it from central nervous system primitive neuroectodermal tumors and from other spinal tumors since it follows a different clinical course and therapeutic outcome.

Entities:  

Keywords:  Adult; dorsal spine; extradural; primitive neuroectodermal tumor

Year:  2017        PMID: 29403254      PMCID: PMC5763599          DOI: 10.4103/jcvjs.JCVJS_70_17

Source DB:  PubMed          Journal:  J Craniovertebr Junction Spine        ISSN: 0974-8237


INTRODUCTION

Primitive neuroectodermal tumors (PNET) are rare tumors that arise from undifferentiated matrix or germinal cells.[12] Annual incidence of these tumors is around 0.2–0.4/100,000.[134] It is a highly malignant and invasive tumor with poor prognosis usually occurring in children and young adults.[1234] Primary spinal PNETs (psPNET) are even rarer, limited to only a few case reports, especially in patients above 50 years of age.[1] We present a case of a 50-year-old female who presented to us with rapidly progressive paraparesis without bladder bowel involvement. Extensive search of English literature has revealed that our patient is only the second case of dorsal spine extradural tumor in patients aged 50 years or above. We also review the literature on the subject and discuss distinguishing features between central nervous system (CNS) PNET and psPNET.

CASE REPORT

A 50-year-old female patient presented to us with tingling sensation over both lower limbs which affected the right side more than the left side for the last 6 weeks. She then developed weakness of both lower limbs which initially affected the right side manifesting as heaviness in legs followed by stiffness and difficulty in walking. Weakness was insidious in onset but rapidly progressed to involve both lower limbs that patient was unable to stand without support in the next 4 weeks. When she came to us, both her lower limbs were severely spastic. Power in both her lower limbs was MRC 1/5. Tone and power in both upper limbs were unaffected. Reflexes in both lower limbs were exaggerated. Bilateral plantars were extensor. She had no sensory deficits. The patient underwent magnetic resonance imaging (MRI) of the cervicodorsal spine [Figure 1] which revealed an heterogeneously enhancing intraspinal tumor at D1–D2 level on the right side causing cord compression and pushing it to the opposite side. The tumor extended into the right D1–D2 foramen with extension into paravertebral area. Noncontrast computed tomography cervical spine showed mild degenerative changes with anterior osteophyte formation and right facet joint arthropathy from C4 to C7 level. The right side D1–D2 neural foramina was wider and the D1 pedicle thinned out as compared to the left side [Figure 2]. With a possible diagnosis of peripheral nerve sheath tumor with cord compression, the patient underwent D1-D2 laminectomy using posterior midline incision in the prone position. A large reddish pink color extra dural tumor extending from C7 to D2 level was seen on the right anterolateral side of the spinal canal pushing the cord to the left side. The tumor began to bulge out of the spinal canal even as the laminectomy was being performed. D1 and D2 right-sided facet joint was also excised to create a corridor to approach the foraminal and extraforaminal/paraspinal part of tumor. There was a clear plane of cleavage between the tumor and adjacent tissues. Right D1 pedicle was thinned out due to compression by the tumor. Gross total excision of the intraspinal part of the tumor was done. The tumor was densely adherent to the right side D1 nerve root which was sacrificed. The wound was then closed in layers. Power and spasticity in both lower limbs started to improve after surgery. At the time of discharge, power in the right lower limb was 2/5 and in the left lower limb was 3/5. Histopathological examination [Figure 3] revealed sheets of monomorphic small round cells with scanty cytoplasm and high nuclear/cytoplasmic ratio and hyperchromatic round nuclei consistent with diagnosis of PNET. It was positive for neuron-specific enolase and CD99. It showed focal expression of synaptophysin and cytokeratin. It was negative for leukocyte common antigen, CD3, and CD20. The Ki-67 proliferation index was 20%. MRI brain and whole body positron emission tomography (PET) scan showed no other tumor sites or distant metastases, and thus a diagnosis of psPNET was established. The patient was then referred to an oncologist for adjuvant therapy.
Figure 1

Magnetic resonance imaging of the cervicodorsal spine. (a) T1 axial showing isointense tumor (asterisk) pushing cord to left (b) T2 sagittal image showing hyperintense lesion causing cord compression. (c) Short tau inversion recovery coronal image showing tumor (arrow head) extending through the foramen, cord (asterisk) being pushed to left. (d) Tumor heterogeneously enhancing to contrast on sagittal and coronal images

Figure 2

(a) Sagittal image showing enlargement of the foramen and thinning of pedicle (arrows). (b) Computed tomography image showing thinned out right side pedicle (arrow)

Figure 3

(a) Monomorphic tumor cells with vesicular chromatin, small nucleoli, and brisk mitotic karyorrhectic activity (H and E, ×40). (b) Diffuse membranous positivity for CD99 (×40). (c) Positivity for neuron-specific enolase (×20)

Magnetic resonance imaging of the cervicodorsal spine. (a) T1 axial showing isointense tumor (asterisk) pushing cord to left (b) T2 sagittal image showing hyperintense lesion causing cord compression. (c) Short tau inversion recovery coronal image showing tumor (arrow head) extending through the foramen, cord (asterisk) being pushed to left. (d) Tumor heterogeneously enhancing to contrast on sagittal and coronal images (a) Sagittal image showing enlargement of the foramen and thinning of pedicle (arrows). (b) Computed tomography image showing thinned out right side pedicle (arrow) (a) Monomorphic tumor cells with vesicular chromatin, small nucleoli, and brisk mitotic karyorrhectic activity (H and E, ×40). (b) Diffuse membranous positivity for CD99 (×40). (c) Positivity for neuron-specific enolase (×20)

DISCUSSION

psPNET or extraskeletal Ewing's sarcoma (ES) of the spine is a rare entity.[1234] It generally occurs in children and young adults (<35 years) in the lumbosacral region.[1] Their incidence in patients >50 years of age is limited to a few case reports [Table 1]. It is highly malignant and invasive tumor and presents as rapidly growing soft tissue mass.[13] PNET belongs to a family of undifferentiated round cell tumors (i.e., neuroblastoma, non-Hodgkin's lymphoma, rhabdomyosarcoma, and ES) and primarily affects CNS. It probably originates from matrix or germinal cells and/or neural crest cells of embryonic neural tube and is believed to have behavioral similarities to ES.[1] Therefore, osseous ES, extraskeletal Ewing's sarcoma (EES), Askin's tumor, and peripheral PNET (pPNET) are grouped together as ES family of tumors.
Table 1

Reported cases of primary spinal primitive neuroectodermal tumor in patients of age 50 years and above

Reported cases of primary spinal primitive neuroectodermal tumor in patients of age 50 years and above The distinction between CNS/central PNET and EES/psPNET [Table 2] is important to establish a diagnosis of psPNET.[134] CNS PNET usually occurs in infants and children and rarely in the elderly. It often presents as spinal intramedullary drop metastases from intracranial PNET whereas psPNET occurs in adolescents and young adults and is usually either extradural or intradural extramedullary. CNS PNET most likely originates from matrix or germinal cells while psPNET originates from neural crest cells. Both types occur rarely after 50 years of age.[1] CNS PNET is not associated with any gender predilection while psPNET has a male preponderance.[14] Our patient was a 50-year-old female. Clinical presentation in both groups tends to be according to the level of involvement, but pain, sensory symptoms, and radicular pain tend to be more common in psPNET.[1] Duration of symptoms tends to be shorter in patients with CNS PNET.[1]
Table 2

Differences between central nervous system primitive neuroectodermal tumor and primary spinal primitive neuroectodermal tumor

Differences between central nervous system primitive neuroectodermal tumor and primary spinal primitive neuroectodermal tumor CNS PNET tends to distribute equally throughout the spine while psPNET tends to occur more commonly in the lumbar spine.[14] Our case had extradural tumor in the upper dorsal spine. Clinical course of both these groups is different. CNS PNET tends to metastasize more commonly and it usually spreads to other sites in CNS while extra CNS metastases are more common in psPNET with lung being the most common site.[13] Fluorodeoxyglucose-PET scan must be done in all cases to rule out metastatic disease. PET scan done on follow-up in our case revealed no distant metastases. Although MRI is an excellent imaging modality for evaluation of spinal tumors, it is difficult to establish a diagnosis of PNET based on imaging characteristics alone.[11] PNETs are usually hypointense-isointense on T1, hyperintense on T2, and enhance heterogeneously to contrast. In this regard, psPNET mimic most of the other spinal tumors such as lymphomas, metastases, chordomas, or schwannomas. Like in our case, sometimes they extend through the neural foramina and are even dumbbell shaped just like neurofibromas.[11] Needless to say, an intracranial lesion must be ruled out to establish a diagnosis of psPNET from “drop metastases” from CNS PNET. Histopathologic examination[14] of PNET characteristically reveals sheets of poorly differentiated small, round, or spindle-shaped cells. Homer Wright rosettes may be sometimes present. On immunohistochemistry, CD 99 expression, which is a 30 or 32 kDa glycoprotein derived from MIC2 gene, is characteristic of psPNET. It also shows chromosomal translocation in t (11;22) (q24;q12) gene while CNS PNET is negative for both. Management of these cases requires urgent operative decompression as they present with rapidly progressive neurological deficits. After confirmation of diagnosis on histopathology, adjuvant chemoradiotherapy is given.[3] Adjuvant chemotherapy may reduce the incidence of distant metastases. Radiotherapy is usually given for residual disease. Inspite of all measures, the prognosis of psPNET tends to be poor with median survival of 1–2 years.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  11 in total

Review 1.  Primitive neuroectodermal tumors of the spine: a comprehensive review with illustrative clinical cases.

Authors:  Jason A Ellis; Robert J Rothrock; Gaetan Moise; Paul C McCormick; Kurenai Tanji; Peter Canoll; Michael G Kaiser; Paul C McCormick
Journal:  Neurosurg Focus       Date:  2011-01       Impact factor: 4.047

2.  Primary spinal epidural Ewing's sarcoma.

Authors:  B S Sharma; V K Khosla; A K Banerjee
Journal:  Clin Neurol Neurosurg       Date:  1986       Impact factor: 1.876

3.  Primary intramedullary primitive neuroectodermal tumor of the cervical spinal cord. Case report.

Authors:  Amit Jain; Rakesh Jalali; Trimurti D Nadkarni; Suash Sharma
Journal:  J Neurosurg Spine       Date:  2006-06

Review 4.  Primary primitive neuroectodermal tumor of the spinal cord: case report and review of the literature.

Authors:  Christian Mawrin; Hans J Synowitz; Elmar Kirches; Evelyn Kutz; Knut Dietzmann; Serge Weis
Journal:  Clin Neurol Neurosurg       Date:  2002-01       Impact factor: 1.876

5.  Primitive neuroectodermal tumors of the cauda equina in adults with no detectable primary intracranial neoplasm--three case studies.

Authors:  J J Kepes; K Belton; U Roessmann; W J Ketcherside
Journal:  Clin Neuropathol       Date:  1985 Jan-Feb       Impact factor: 1.368

6.  Peripheral primitive neuroectodermal tumor of the cauda equina in an elderly patient. Case report.

Authors:  Elizabeth Fabre; Rémy Guillevin; Fabrice Chretien; Caroline Le Guerinel; Hugues Duffau
Journal:  J Neurosurg Spine       Date:  2006-07

7.  Primary primitive neuroectodermal tumor of the cauda equina.

Authors:  P A Isotalo; C Agbi; B Davidson; A Girard; S Verma; S J Robertson
Journal:  Hum Pathol       Date:  2000-08       Impact factor: 3.466

Review 8.  Intraspinal primitive neuroectodermal tumors: Report of four cases and review of the literature.

Authors:  Chen Jingyu; Song Jinning; Meng Hui; Feng Hua
Journal:  Neurol India       Date:  2009 Sep-Oct       Impact factor: 2.117

9.  Primary spinal extradural Ewing's sarcoma (primitive neuroectodermal tumor): Report of a case and meta-analysis of the reported cases in the literature.

Authors:  Saeed Saeedinia; Mohsen Nouri; Meysam Alimohammadi; Hedieh Moradi; Abbas Amirjamshidi
Journal:  Surg Neurol Int       Date:  2012-05-14

10.  Intracranial metastasis from primary spinal primitive neuroectodermal tumor.

Authors:  Rajesh Kumar Ghanta; Kalyan Koti; Venkata Sateesh K Ghanta; Ramesh Teegala
Journal:  Asian J Neurosurg       Date:  2013-01
View more
  1 in total

1.  Outcome of multidisciplinary treatment of peripheral primitive neuroectodermal tumor.

Authors:  Yidi Liu; Yan Yuan; Fuquan Zhang; Ke Hu; Jie Qiu; Xiaorong Hou; Junfang Yan; Xin Lian; Shuai Sun; Zhikai Liu; Jie Shen
Journal:  Sci Rep       Date:  2020-09-24       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.